Latest total current liabilities for KPL.BO: $2.6B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Kwality Pharmaceuticals Limited (KPL.BO) currently reports a total current liabilities of $2.6B as of September 2026. That compares with $1.7B in the prior-year period — up 52.9% year over year. Use the charts on this page to explore Kwality Pharmaceuticals Limited's total current liabilities history and peer comparisons.
Kwality Pharmaceuticals Limited's total current liabilities increased from $1.7B to $2.6B — a 52.9% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Kwality Pharmaceuticals Limited reported $2.6B in total current liabilities as of September 2026. That compares with $1.7B in the prior-year period — up 52.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total current liabilities of $2.6B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kwality Pharmaceuticals Limited, and consider following KPL.BO for alerts when major investors trade the stock.